HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shingo Kamoshida Selected Research

Orotate Phosphoribosyltransferase

1/2016Orotate phosphoribosyltransferase is overexpressed in malignant pleural mesothelioma: Dramatically responds one case in high OPRT expression.
8/2008Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
7/2008[Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
10/2007[Orotate phosphoribosyltransferase levels in gastric carcinoma and normal gastric mucosa - correlation with thymidylate synthase and dihydropyrimidine dehydrogenase levels and the changes after neoadjuvant chemotherapy].
1/2007Levels and expressions of orotate phosphoribosyltransferase in gastric carcinoma and normal gastric mucosa tissues.
8/2006[Clinical and prognostic significance of protein and gene expression of orotate phosphoribosyltransferase in gastric carcinoma].
4/2006[Clinicopathological significance of orotate phosphoribosyltransferase in gastric carcinoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shingo Kamoshida Research Topics

Disease

20Neoplasms (Cancer)
09/2022 - 08/2004
12Carcinoma (Carcinomatosis)
09/2021 - 04/2006
11Colorectal Neoplasms (Colorectal Cancer)
07/2019 - 08/2004
5Stomach Neoplasms (Stomach Cancer)
11/2016 - 05/2008
5Adenocarcinoma
12/2014 - 10/2006
4Breast Neoplasms (Breast Cancer)
01/2015 - 11/2005
3Lung Neoplasms (Lung Cancer)
11/2019 - 07/2014
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2021 - 05/2010
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2018 - 07/2017
2Neoplasm Metastasis (Metastasis)
11/2016 - 09/2012
2Triple Negative Breast Neoplasms
01/2015 - 05/2014
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2014 - 05/2010
2Lymphatic Metastasis
09/2012 - 07/2008
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2022
1Esophageal Squamous Cell Carcinoma
04/2022
1Wilms Tumor (Wilm's Tumor)
01/2022
1Squamous Cell Carcinoma of Head and Neck
09/2021
1Pyogenic Granuloma
11/2019
1Leukopenia
09/2019
1Splenomegaly
09/2019
1Glomerulonephritis
09/2019
1Diabetes Mellitus
01/2017
1Insulin Resistance
01/2017
1Malignant Mesothelioma
01/2016
1Prostatic Neoplasms (Prostate Cancer)
12/2015
1Endotoxemia
08/2015
1Inflammation (Inflammations)
08/2015
1Orchitis
08/2015
1Colonic Neoplasms (Colon Cancer)
12/2014
1Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2014

Drug/Important Bio-Agent (IBA)

11EnzymesIBA
02/2018 - 11/2005
10Thymidylate SynthaseIBA
02/2018 - 08/2004
9Proteins (Proteins, Gene)FDA Link
09/2022 - 04/2006
9Fluorouracil (Carac)FDA LinkGeneric
02/2018 - 08/2004
7Orotate PhosphoribosyltransferaseIBA
01/2016 - 04/2006
5Messenger RNA (mRNA)IBA
07/2017 - 08/2006
5Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
08/2008 - 08/2006
4Biomarkers (Surrogate Marker)IBA
07/2017 - 07/2013
4Organic Cation Transporter 2IBA
01/2015 - 01/2014
3DNA (Deoxyribonucleic Acid)IBA
02/2018 - 04/2012
3SurvivinIBA
12/2016 - 01/2013
3Caspase 9IBA
12/2014 - 12/2011
3Biological ProductsIBA
01/2014 - 10/2004
3Paclitaxel (Taxol)FDA LinkGeneric
06/2013 - 05/2008
2Monoclonal AntibodiesIBA
11/2019 - 07/2014
2Phosphotransferases (Kinase)IBA
09/2019 - 01/2014
2Copper Transporter 1IBA
02/2018 - 06/2013
2Carboplatin (JM8)FDA LinkGeneric
02/2018 - 06/2013
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2016 - 10/2006
2Antineoplastic Agents (Antineoplastics)IBA
12/2015 - 05/2008
2taxaneIBA
01/2015 - 05/2014
2AnthracyclinesIBA
01/2015 - 05/2014
2Peptides (Polypeptides)IBA
05/2014 - 06/2013
2AnionsIBA
05/2014 - 06/2013
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2014 - 01/2014
2Organic Anion TransportersIBA
01/2014 - 07/2013
2Leucovorin (Folinic Acid)FDA Link
01/2014 - 07/2013
2Thymidine PhosphorylaseIBA
08/2008 - 05/2008
2Indicators and Reagents (Reagents)IBA
07/2008 - 08/2004
2Cyclin-Dependent Kinase Inhibitor p16IBA
10/2004 - 08/2004
2ParaffinIBA
10/2004 - 08/2004
1Transforming Growth Factors (Transforming Growth Factor)IBA
09/2022
1Small Interfering RNA (siRNA)IBA
09/2022
1VimentinIBA
09/2022
1Organic Cation Transporter 1IBA
04/2022
1podocalyxinIBA
01/2022
1ChromatinIBA
09/2021
1Coloring Agents (Dyes)IBA
09/2021
1RamucirumabIBA
11/2019
1Angiogenesis InhibitorsIBA
11/2019
1Immunoglobulin G (IgG)IBA
11/2019
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
11/2019
1anti-dsDNA autoantibodyIBA
09/2019
1Calcibiotic Root Canal SealerIBA
07/2019
1CrizotinibIBA
01/2019
1Anaplastic Lymphoma KinaseIBA
01/2019
1alectinibIBA
01/2019
1Pemetrexed (MTA)FDA Link
07/2017
1Folic Acid (Vitamin M)FDA LinkGeneric
07/2017
1ZincIBA
01/2017
1Trace Elements (Biometals)IBA
01/2017
1Caspase 3 (Caspase-3)IBA
08/2015
1LipopolysaccharidesIBA
08/2015
1Interleukin-18 (Interleukin 18)IBA
08/2015
1CytokinesIBA
08/2015
1Death Domain ReceptorsIBA
08/2015
1Copper Transport ProteinsIBA
01/2015
1PlatinumIBA
01/2015
1Cisplatin (Platino)FDA LinkGeneric
01/2015
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
12/2014
1Gefitinib (Iressa)FDA Link
07/2014
1Imatinib Mesylate (Gleevec)FDA Link
07/2014
1Rituximab (Mabthera)FDA Link
07/2014
1Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2014
1Hormones (Hormone)IBA
07/2014

Therapy/Procedure

18Drug Therapy (Chemotherapy)
04/2022 - 08/2004
4Therapeutics
12/2015 - 01/2014
4Neoadjuvant Therapy
01/2015 - 10/2007
2Adjuvant Chemotherapy
07/2008 - 10/2004
1TP protocol
01/2015